You are here:

diclofenac (Mobigel Spray)

Advice

In the absence of a submission from the holder of the marketing authorisation:        

diclofenac 4% spray gel (Mobigel Spray ®): is not recommended for use in NHSScotland.                               

Indication under review:  for the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: diclofenac (Mobigel Spray)
SMC Drug ID: 667/10
Manufacturer: Goldshield Pharmaceuticals Limited
Indication: For the local symptomatic relief of mild to moderate pain and inflammation following acute blunt trauma of small and medium-sized joints and periarticular structures
BNF Category:
Sub Category: 10.1 Drugs used in rheumatic diseases and gout
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 13 December 2010

Back